SOTYKTU
NDC 0003-0895, deucravacitinib, tablet, film coated, from E.R. Squibb & Sons, L.L.C..
- Product NDC
- 0003-0895
- Status
- Listed
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214958
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0003-0895 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEUCRAVACITINIB6 mg/1
Pharmacologic classes
Tyrosine Kinase 2 Inhibitor [EPC]; Tyrosine Kinase 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0003-0895-11 | 00003089511 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-0895-11) |
| 0003-0895-91 | 00003089591 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0003-0895-91) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ff4d7258-5068-4cdf-9692-8cae04c3198e
Use it
Look up 0003-0895 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0003-0895 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0003-0895. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.